Cargando…
Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
BACKGROUND & OBJECTIVES: COVID-19 cases have been rising rapidly in countries where the SARS-CoV-2 variant of concern (VOC), Omicron (B.1.1.529) has been reported. We conducted a study to describe the epidemiological and clinical characteristics and outcomes of COVID-19 patients with ‘S’ gene ta...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552397/ https://www.ncbi.nlm.nih.gov/pubmed/35417991 http://dx.doi.org/10.4103/ijmr.ijmr_312_22 |
_version_ | 1784806242177253376 |
---|---|
author | Raju, Mohan Kumar Thangaraj, Jeromie Wesley Vivian Selvavinayagam, T.S. Somasundaram, A. Parthipan, K. Sivadoss, Raju Sabarinathan, R. Subramaniam, Sudharshini Rozario, Amanda G.A. Rani, Sudha D. Suganya, E. Murhekar, Manoj V. |
author_facet | Raju, Mohan Kumar Thangaraj, Jeromie Wesley Vivian Selvavinayagam, T.S. Somasundaram, A. Parthipan, K. Sivadoss, Raju Sabarinathan, R. Subramaniam, Sudharshini Rozario, Amanda G.A. Rani, Sudha D. Suganya, E. Murhekar, Manoj V. |
author_sort | Raju, Mohan Kumar |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: COVID-19 cases have been rising rapidly in countries where the SARS-CoV-2 variant of concern (VOC), Omicron (B.1.1.529) has been reported. We conducted a study to describe the epidemiological and clinical characteristics and outcomes of COVID-19 patients with ‘S’ gene target failure (SGTF, suspected Omicron). Furthermore, their clinical outcomes with COVID-19 patients with non-SGTF (non-Omicron) were also compared. METHODS: This study was conducted in Tamil Nadu, India, between December 14, 2021 and January 7, 2022 among patients who underwent reverse transcription-PCR testing for SARS-CoV-2 in four laboratories with facilities for S gene screening. Consecutively selected COVID-19 patients with SGTF were telephonically contacted, seven and 14 days respectively after their date of positive result to collect information on the socio-demographic characteristics, previous history of COVID-19, vaccination status and clinical course of illness along with treatment details. To compare their outcomes with non-SGTF patients, one randomly suspected non-Omicron case for every two suspected Omicron cases from the line-list were selected, matching for the date of sample collection and the testing laboratory. RESULTS: A total of 1175 SGTF COVID-19 patients were enrolled for this study. Almost 6 per cent (n=72) reported a history of previous infection. 141 (13.5%) suspected Omicron cases were non-vaccinated, while 148 (14.2%) and 703 (67.4%) had received valid one and two doses of COVID-19 vaccines, respectively. Predominant symptoms reported included fever (n=508, 43.2%), body pain (n=275, 23.4%), running nose (n=261, 22.2%) and cough (n=249, 21.2%). Five (0.4%) of the 1175 suspected Omicron cases required oxygen supplementation as compared to ten (1.6%) of the 634 suspected non-Omicron cases. No deaths were reported among omicron suspects, whereas there were four deaths among suspected non-Omicron cases. INTERPRETATION & CONCLUSIONS: Majority of the suspected Omicron cases had a mild course of illness. The overall severity of these cases was less compared to the suspected non-Omicron cases. |
format | Online Article Text |
id | pubmed-9552397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-95523972022-10-12 Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022 Raju, Mohan Kumar Thangaraj, Jeromie Wesley Vivian Selvavinayagam, T.S. Somasundaram, A. Parthipan, K. Sivadoss, Raju Sabarinathan, R. Subramaniam, Sudharshini Rozario, Amanda G.A. Rani, Sudha D. Suganya, E. Murhekar, Manoj V. Indian J Med Res Original Article BACKGROUND & OBJECTIVES: COVID-19 cases have been rising rapidly in countries where the SARS-CoV-2 variant of concern (VOC), Omicron (B.1.1.529) has been reported. We conducted a study to describe the epidemiological and clinical characteristics and outcomes of COVID-19 patients with ‘S’ gene target failure (SGTF, suspected Omicron). Furthermore, their clinical outcomes with COVID-19 patients with non-SGTF (non-Omicron) were also compared. METHODS: This study was conducted in Tamil Nadu, India, between December 14, 2021 and January 7, 2022 among patients who underwent reverse transcription-PCR testing for SARS-CoV-2 in four laboratories with facilities for S gene screening. Consecutively selected COVID-19 patients with SGTF were telephonically contacted, seven and 14 days respectively after their date of positive result to collect information on the socio-demographic characteristics, previous history of COVID-19, vaccination status and clinical course of illness along with treatment details. To compare their outcomes with non-SGTF patients, one randomly suspected non-Omicron case for every two suspected Omicron cases from the line-list were selected, matching for the date of sample collection and the testing laboratory. RESULTS: A total of 1175 SGTF COVID-19 patients were enrolled for this study. Almost 6 per cent (n=72) reported a history of previous infection. 141 (13.5%) suspected Omicron cases were non-vaccinated, while 148 (14.2%) and 703 (67.4%) had received valid one and two doses of COVID-19 vaccines, respectively. Predominant symptoms reported included fever (n=508, 43.2%), body pain (n=275, 23.4%), running nose (n=261, 22.2%) and cough (n=249, 21.2%). Five (0.4%) of the 1175 suspected Omicron cases required oxygen supplementation as compared to ten (1.6%) of the 634 suspected non-Omicron cases. No deaths were reported among omicron suspects, whereas there were four deaths among suspected non-Omicron cases. INTERPRETATION & CONCLUSIONS: Majority of the suspected Omicron cases had a mild course of illness. The overall severity of these cases was less compared to the suspected non-Omicron cases. Wolters Kluwer - Medknow 2022-01 /pmc/articles/PMC9552397/ /pubmed/35417991 http://dx.doi.org/10.4103/ijmr.ijmr_312_22 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Raju, Mohan Kumar Thangaraj, Jeromie Wesley Vivian Selvavinayagam, T.S. Somasundaram, A. Parthipan, K. Sivadoss, Raju Sabarinathan, R. Subramaniam, Sudharshini Rozario, Amanda G.A. Rani, Sudha D. Suganya, E. Murhekar, Manoj V. Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022 |
title | Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022 |
title_full | Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022 |
title_fullStr | Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022 |
title_full_unstemmed | Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022 |
title_short | Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022 |
title_sort | clinical profile of patients infected with suspected sars-cov-2 omicron variant of concern, tamil nadu, india, december 2021-january 2022 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552397/ https://www.ncbi.nlm.nih.gov/pubmed/35417991 http://dx.doi.org/10.4103/ijmr.ijmr_312_22 |
work_keys_str_mv | AT rajumohankumar clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT thangarajjeromiewesleyvivian clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT selvavinayagamts clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT somasundarama clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT parthipank clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT sivadossraju clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT sabarinathanr clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT subramaniamsudharshini clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT rozarioamandaga clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT ranisudhad clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT suganyae clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 AT murhekarmanojv clinicalprofileofpatientsinfectedwithsuspectedsarscov2omicronvariantofconcerntamilnaduindiadecember2021january2022 |